FDA Inspection 677829 — Diamond Institute For Infertility And Menopause

Diamond Institute For Infertility And Menopause — FEI 3003945103

The FDA completed an inspection of Diamond Institute For Infertility And Menopause on Aug 18, 2010 in Millburn, NJ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Biologics.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Aug 18, 2010
Fiscal Year
2010
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Millburn, NJ (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.